---
$id: https://graph.org.ai/products/commodity/51263010
$type: Product
source: UNSPSC
code: "51263010"
title: "Terazosin hydrochloride"
class: "51263000"
classTitle: "Adrenergic blocking agent piperazines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Terazosin hydrochloride

**UNSPSC Code**: 51263010
**Class**: [Adrenergic blocking agent piperazines](Adrenergic blocking agent piperazines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C19H25N5O4.ClH.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D32S14F082, chemically known as 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine but more generally known as terazosin hydrochloride, which bears US NIH Compound Identifier 5401. European Medicines Agency schedules Terazosin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04722MIG. Most nations, for tariff and trade purposes, schedule terazosin hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, TERAZOSIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Terazosin hydrochloride bears US NLM identifiers UMLS ID C0770137 and NCI Concept Code C29491. SMILES: COC1CC2C(CC1OC)NC(NC2N)N3CCN(CC3)C(=O)C4CCCO4.O.O.CL.

